Tech Company Financing Transactions
PROCEPT BioRobotics Funding Round
PROCEPT BioRobotics secured a $42 million funding round on 7/8/2015. Investors included Novo Ventures and private investors.
Transaction Overview
Company Name
Announced On
7/8/2015
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Undisclosed
Investors
Novo Ventures (Lead Investor) (Jack Nielsen)
Proceeds Purpose
PROCEPT will use the proceeds from the financing for a limited commercial launch of AquaBeam in targeted international markets and to conduct the WATER study (Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue), a randomized blinded controlled clinical trial.
Company Information
Company Status
Publicly-held
Industry
Robotics
Mailing Address
900 Island Dr. 210
Redwood Shores, CA 94065
USA
Redwood Shores, CA 94065
USA
Phone
Website
Email Address
Overview
PROCEPT BioRobotics is a medical device company that develops a novel minimally invasive technology to surgically treat prostate disease. The first product developed is the AquaBeam, an intelligent image-guided robotic system delivering Aquablation, a personalized waterjet tissue resection modality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Reza Zadno
Vice President
Matthew Salkeld
VP - General Counsel
Alaleh Nouri
VP - R & D
Surag Mantri
VP - Regulatory Affairs
Bijesh Chandran
VP - Regulatory Affairs
Barry Templin
Browse more venture capital transactions:
Prev: 7/8/2015: LANDR venture capital transaction
Next: 7/8/2015: GoodWorld venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs